Literature DB >> 12217411

Mechanisms underlying mast cell influence on EAE disease course.

Melissa A Brown1, Melinda B Tanzola, Michaela Robbie-Ryan.   

Abstract

It is well established that CD4(+) T cells are of central importance in mediating the autoimmune destruction associated with the neurological demyelinating disease Multiple sclerosis (MS) and the rodent model of MS, EAE (experimental allergic encephalomyelitis). However, other cells also play a critical role in the inflammatory events that lead to the varying degrees of myelin and axonal damage observed in this disease syndrome. In this review, we present evidence that mast cells, best studied in the context of allergic disease, contribute to EAE disease pathology. Using mast cell-deficient mice, we demonstrate that mast cells are necessary for the full manifestation of MOG-induced EAE disease and show that cross-linking of Fc receptors is one mechanism of mast cell activation in disease. In addition, we provide evidence that mast cells exert influences outside the CNS, perhaps through the effects on the generation of the anti-MOG T cell response.

Entities:  

Mesh:

Year:  2002        PMID: 12217411     DOI: 10.1016/s0161-5890(02)00091-3

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Brain mast cell relationship to neurovasculature during development.

Authors:  Mona Khalil; Jocelyn Ronda; Michael Weintraub; Kim Jain; Rae Silver; Ann-Judith Silverman
Journal:  Brain Res       Date:  2007-07-26       Impact factor: 3.252

3.  Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.

Authors:  D Kempuraj; M Tagen; B P Iliopoulou; A Clemons; M Vasiadi; W Boucher; M House; A Wolfberg; T C Theoharides
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

Review 4.  Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Authors:  Daniel Elieh-Ali-Komi; Yonghao Cao
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 5.  Regulation of mast cell responses in health and disease.

Authors:  Alasdair M Gilfillan; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2011       Impact factor: 2.214

6.  P2 receptor-mediated signaling in mast cell biology.

Authors:  Elena Bulanova; Silvia Bulfone-Paus
Journal:  Purinergic Signal       Date:  2009-11-17       Impact factor: 3.765

7.  Our perception of the mast cell from Paul Ehrlich to now.

Authors:  Michael A Beaven
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

8.  Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.

Authors:  Patrick Vermersch; Rabah Benrabah; Nicolas Schmidt; Hélène Zéphir; Pierre Clavelou; Cyrille Vongsouthi; Patrice Dubreuil; Alain Moussy; Olivier Hermine
Journal:  BMC Neurol       Date:  2012-06-12       Impact factor: 2.474

9.  Interplaying factors that effect multiple sclerosis causation and sustenance.

Authors:  Emanuel Calenoff
Journal:  ISRN Neurol       Date:  2012-01-23

Review 10.  Mast cell and autoimmune diseases.

Authors:  Yunzhi Xu; Guangjie Chen
Journal:  Mediators Inflamm       Date:  2015-04-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.